MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics today announced the appointment of Richard U. De Schutter as Chairman of the Company’s Board of Directors. Mr. De Schutter has over 27 years’ experience in the pharmaceutical industry, including as the former CEO of DuPont Pharmaceuticals and of G.D. Searle & Co.
